Studies on the irreversibility of cellular senescence and its role in vivo
Studies on the irreversibility of cellular senescence and its role in vivo
批准号:
18370080
负责人:
HARA Eiji
金额:
$11.5万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cellular senescence is a state of permanent cell cycle arrest that can be induced by a variety of potentially oncogenic stresses. It is therefore proposed as a fail-safe mechanism that protects normal cells from losing control of cell division and forming tumors. Although molecular mechanism inducing cellular senescence has been well studied in tissue culture cells, very little is known about how senescent cell cycle arrest is stably maintained in vivo. To gain further insight into the roles and mechanisms of cellular senescence in vivo, we attempted to elucidate molecular mechanisms underlying irreversibility of senescent cell cycle arrest. Towards this end, we utilized a conditionally immortalized cell line that express temperature-sensitive SV4- large T antigen. Using this cell line, we uncovered that p 16^<INK4a> tumor suppressor blocks not only DNA replication but also cytokinesis through activating reactive oxygen species (ROS) -PKCδsignalling in senescent human cells. Importantly, once activated by ROS, PKCδ promotes further generation of ROS, thus establishing a positive feedback loop to sustain ROS-PKCδsignalling. Sustained activation of ROS-PKCδ signalling irreversibly blocks cytokinesis, at least partly through blocking the function of LATS1/WARTS, a mitotic exit network kinase required for cytokinesis. We also established the transgenic mice lines expressing the firefly luciferase under the control of the senescence-associated gene promoter. In conjunction with a noninvasive bioluminescence imaging technique, these transgenic mice lines enabled us to monitor the senescence-associated gene expression in vivo. Using this system, we were able to unveil the dynamics of senescence signaling throughout entire lifespan in vivo. We hope that these studies will provide new insights into the development of cancer and open up new possibilities for its control.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Visualizing the dynamics of p21^<Wafl/Cipl> cyclin-dependent kinase inhibitor expression in living animals.
可视化活体动物中 p21^<Wafl/Cipl> 细胞周期蛋白依赖性激酶抑制剂表达的动态。
DOI:
--
发表时间:
2007
期刊:
Proceedings of the National Academy of Sciences of the United States of America 104
影响因子:
--
作者:
[河尻愛恵, 稲垣昌樹, Naoko Ohtani]
通讯作者:
Naoko Ohtani
Visualizing the dynamics of p21^<wafl/Cipl> cyclin-dependent kinase inhibitor expression in living animals
活体动物中 p21^<wafl/Cipl> 细胞周期蛋白依赖性激酶抑制剂表达动态的可视化
DOI:
--
发表时间:
2007
期刊:
Proceedings of the National Academy of Sciences of the United States of America 104
影响因子:
--
作者:
[Akiko, Takahashi, Naoko Ohtani]
通讯作者:
Naoko Ohtani
The role of p16 CDK inhibitor in cell cycle control and senescence
p16 CDK抑制剂在细胞周期控制和衰老中的作用
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Akiko, Takahashi, Eiji Hara, Eiji Hara]
通讯作者:
Eiji Hara
DOI:
10.1038/ncb1491
发表时间:
2006-11-01
期刊:
NATURE CELL BIOLOGY
影响因子:
21.3
作者:
[Takahashi, Akiko, Ohtani, Naoko, Hara, Eiji]
通讯作者:
Hara, Eiji
Visualizing the dynamics of p21^<Wafl/cipl>yclin dependent kinase inhibitor expression in living animals
活体动物中 p21^<Wafl/cipl>yclin 依赖性激酶抑制剂表达动态的可视化
DOI:
--
发表时间:
2007
期刊:
Proceedings of the National Academy of Sciences of the United States of America 104
影响因子:
--
作者:
[Naoko, Ohtani]
通讯作者:
Ohtani
共 6 条
Understanding of the anti-apoptotic mechanisms in senescent cells
-
批准号:24650625
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:HARA Eiji
-
依托单位:
Study on senescence-associated tumor promotion
-
批准号:23300352
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$14.06万
-
财政年份:2011
-
负责人:HARA Eiji
-
依托单位:
Visualizing the dynamics of senescence response in vivo
-
批准号:20390094
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2008
-
负责人:HARA Eiji
-
依托单位:
Regulation of INK4a/ARF gene locus and its role in cellular senescence
-
批准号:17013064
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$31.74万
-
财政年份:2005
-
负责人:HARA Eiji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ADAMTS1靶向MDM2/RBM15/hnRNPC/p16轴诱导心脏衰老的作用机制研究
-
批准号:2026JJ81629
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蒋路平
-
依托单位:
P16胶体金抗体试纸条在宫颈癌筛查中的应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
香烟烟雾通过Decorin-PAI-1-p53/p16调控肺泡成纤维细胞衰老在肺气肿的作用及干预研究
-
批准号:82300047
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:胡蔚萍
-
依托单位:
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
-
批准号:82371873
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:乔洁
-
依托单位:
细胞核变形与P16 DNA甲基化协同促进CDKN2A基因拷贝数缺失
-
批准号:82372586
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:邓大君
-
依托单位:
辐射激活IFN-γ/RGS1/p16信号引起巨噬细胞衰老促进RIPF发生发展的机制研究
-
批准号:82304071
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:苏路路
-
依托单位:
Bmal1/p16正反馈环路调控椎间盘退变的机制研究
-
批准号:82372483
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:任永信
-
依托单位:
p16-SP1/Sirt6/NF-κb在糖尿病小鼠RGCs凋亡中的作用及机制
-
批准号:2023JJ30748
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:丁纯
-
依托单位:
基于Klotho/TGF-β1/Smad3/p16通路研究新冠病毒N蛋白介导的AKI向CKD转化机制及槲皮素的干预作用
-
批准号:82304910
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:吴文静
-
依托单位:
m6A甲基化酶METTL14介导PSMD14/Sp1/p16通路调控香烟烟雾致肺细胞衰老及其促肺癌侵袭转移机制研究
-
批准号:82373613
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:李建祥
-
依托单位: